Body substance precautions
Grosskopf, E.J.
Radiology Management 10(2): 14-16
1988
ISSN/ISBN: 0198-7097 PMID: 10314282 Document Number: 322148
Document emailed within 1 workday
Related Documents
Reda, A.A.; Vandeweerd, J.-M.; Syre, T.R.; Egata, G. 2009: HIV/AIDS and exposure of healthcare workers to body fluids in Ethiopia: attitudes toward universal precautions Journal of Hospital Infection 71(2): 163-169Bondarev, I.M.; Zhigalina, L.I.; Cherniĭ, A.N. 1976: Device for introducing a drug substance into the body Meditsinskaia Tekhnika 6: 17-19
Nakamura, T. 2003: Non-drug substance (over intake of foods which are contained purine body, fat and fructose) Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 1): 338-342
Breu, K. 1970: Precautions against injudicious tuberculosis patients. Experiences in carrying out precautions against injudicious infectious tuberculosis patients in the German Federal Republic Wiener Medizinische Wochenschrift 120(51): 985-988
Yakimova, K.; Ovtcharov, R. 1988: Effect of the body temperature upon central administration of substance P--the role of adrenalectomy and GABA-activation Acta Physiologica et Pharmacologica Bulgarica 14(4): 65-70
Landheim, A.S.; Bakken, K.; Vaglum, P. 2006: What characterizes substance abusers who commit suicide attempts? Factors related to Axis i disorders and patterns of substance use disorders. a study of treatment-seeking substance abusers in Norway European Addiction Research 12(2): 102-108
Shoji, M.; Harigaya, Y.; Okamoto, K.; Yamaguchi, H.; Hirai, S. 1988: The study of neuroactive substance within senile plaques--with special reference to somatostatin and substance P Rinsho Shinkeigaku 28(1): 67-73
Browne, F.A.; Wechsberg, W.M. 2010: The intersecting risks of substance use and HIV risk among substance-using South African men and women Current Opinion in Psychiatry 23(3): 205-209
Floyd, L.J.; Hedden, S.; Lawson, A.; Salama, C.; Moleko, A.Gloria.; Latimer, W. 2010: The association between poly-substance use, coping, and sex trade among black South African substance users Substance use and Misuse 45(12): 1971-1987
Farmer, R.F.; Kosty, D.B.; Seeley, J.R.; Gau, J.M.; Klein, D.N. 2019: Family Aggregation of Substance use Disorders: Substance Specific, Nonspecific, and Intrafamilial Sources of Risk Journal of Studies on Alcohol and Drugs 80(4): 462-471
Whitesell, N.Rumbaugh.; Beals, J.; Mitchell, C.M.; Manson, S.M.; Turner, R.Jay.; Big Crow, C.K.; Buchwald, D.; Chambers, B.; Christensen, M.L.; Dillard, D.A.; DuBray, K.; Espinoza, P.A.; Fleming, C.M.; Wilson Frederick, A.; Gone, J.; Gurley, D.; Jervis, L.L.; Jim, S.M.; Kaufman, C.E.; Klein, S.A.; Lee, D.; Manson, S.M.; McNulty, M.C.; Middlebrook, D.L.; Moore, L.A.; Nez, T.D.; Norton, I.M.; Novins, D.K.; O'Nell, T.; Orton, H.D.; Randall, C.J.; Sam, A.; Shore, J.H.; Simpson, S.G.; Yazzie, L. 2009: Childhood exposure to adversity and risk of substance-use disorder in two American Indian populations: the meditational role of early substance-use initiation Journal of studies on alcohol and drugs 70(6): 971-981
Fisun, A.I.; Kuvshinov, K.É; Shamreĭ, V.K.; Alekseev, V.V.; Goncharenko, A.I.; Pastushenkov, A.V.; Tikhenko, V.V. 2014: Prophylaxis of substance abuse in the Armed Forces: organization and performance of screening. Problem of substance dependence disorders is the actual for many countries in the world and affects on health of servicemen Voenno-Meditsinskii Zhurnal 335(3): 4-12
Rafael, A.; Campbell, B.; Pequegnat, D. 1991: Precautions Canadian Nurse 87(4): 6; 8
1999: Center for Mental Health Services; Center for Substance Abuse Treatment; fiscal year 1999 funding opportunity. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services (CMHS), Center for Substance Abuse Treatment (CSAT). Notice of availability of funds for cooperative agreements for CMHS/CSAT collaborative program on homeless families: women with psychiatric, substance u Federal register 64(108): 30350-30352
Bradley, C.; Babb, J.; Davies, J.; Ayliffe, G. 1986: Taking precautions Nursing Times 82(10): 70-73
Velázquez, R.A.; Kitto, K.F.; Larson, A.A. 1997: CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse Journal of Pharmacology and Experimental Therapeutics 281(3): 1231-1237
1990: American Academy of Pediatrics Provisional Committee on Substance Abuse: Selection of substance abuse treatment programs Pediatrics 86(1): 139-140
Okamoto, Y.; Shirotori, K.; Kudo, K.; Ishikawa, K.; Ito, E.; Togawa, K.; Saito, I. 1993: Cytokine expression after the topical administration of substance P to human nasal mucosa. the role of substance P in nasal allergy Journal of Immunology 151(8): 4391-4398
Sonksen, D. 1996: The right precautions stem epidemics Provider 22(11): 109
Carswell, J.W. 1989: Precautions against HIV transmission in hospitals Tropical Doctor 19(3): 131-132